Study of Betaferon adherence in patients with multiple sclerosis treated with interferon beta-1b (ADHERENCE)
The primary objective of the study is to evaluate the adherence to the treatment with interferon beta-1b, in patients diagnosed with isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RRMS), or secondary progressive multiple sclerosis (SPMS) who had more than 6 months in treatment.
- Patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) or patients with a first outbreak or clinically isolated syndrome (CIS) that carry more than 6 months in treatment with interferon beta-1b
No Exclusion Criteria Available
Cross-sectional retrospective study of therapeutic compliance in patients with multiple sclerosis treated with interferon beta-1b